Early Aspirin for Acute Ischemic Stroke
Mark M. Landreneau
Abstract
Mark M. Landreneau
Abstract
Abstract This chapter provides a summary of a landmark study in vascular neurology. Is early aspirin use an effective treatment for acute ischemic stroke? Starting with that question, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. In patients with acute ischemic stroke, a medium dose of aspirin daily is effective at reducing mortality and the risk for recurrent ischemic stroke, though the absolute benefits are modest. The chapter briefly reviews other relevant studies and information, and concludes with a relevant clinical case.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract This chapter provides a summary of a landmark study in vascular neurology. Is early aspirin use an effective treatment for acute ischemic stroke? Starting with that question, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. In patients with acute ischemic stroke, a medium dose of aspirin daily is effective at reducing mortality and the risk for recurrent ischemic stroke, though the absolute benefits are modest. The chapter briefly reviews other relevant studies and information, and concludes with a relevant clinical case.
Key concepts: Aspirin, Medicine, Neurology, Ischemic stroke, Stroke (engine), Acute stroke, Intensive care medicine, Cardiology